Related Topics News -

     
 Title only   |   Print 
     
歌禮製藥兩激動劑固定劑量複方製劑進行臨床開發

2026-07-15T  
歌禮製藥擬斥最多3億元回購股份

2026-06-30T  
藥明生物藥明康德升近6%及9% 花旗:中國醫療保健板塊估值吸引呈良好入市點

2026-06-24T  
歌禮三項關鍵研究結果在美國糖尿病協會年會亮相

2026-06-08T  
《大行》花旗:市場對可能限制生物製藥技術出口政策過度反應 提供買入良機

2026-06-05T  
石藥收跌4%恆瑞醫藥(01276.)挫7% 花旗:美擬限對華生物技術投資料通過機率低 調整為醫藥板塊買入良機

2026-06-03T  
歌禮製藥於歐洲肥胖症大會上以壁報形式展示多個項目

2026-05-06T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.